- Varenicline: implications for the field
- Marketing stop smoking services to
help reach targets
- Professional standards, clinical supervision
- Smoking cessation and young people
- Where next for smoking cessation?
Conference planning group
Andy McEwen, Cancer Research UK Health Behaviour Unit, University College London and Hayden McRobbie, University of Auckland.
Miriam Armstrong, Pharmacy Health Link, RPSGB; Deborah Arnott, Action on Smoking and Health (ASH); Steve Crone, QUIT; Linda Durgan, All Wales Smoking Cessation Service; Trish Grierson, Dumfries and Galloway Primary Care NHS Trust; Peter Hajek, Tobacco Dependence Research and Treatment Centre, Barts and the London Queen Mary's School of Medicine and Dentistry; Elspeth Lee, Behaviour Research and Tobacco Control, Cancer Research UK; Gerry McElwee, ASH Northern Ireland; Ann McNeill, University of Nottingham; Lesley Owen, National Institute for Clinical Excellence; Gay Sutherland, Maudsley Hospital Smoking Cessation Clinic; Robert West, Cancer Research UK Health Behaviour Unit, University College London; Ben Youdan, No Smoking Day.
Action on Smoking and Health (ASH); ASH Scotland; ASH Wales; ASH Northern Ireland; Association for the Treatment of Tobacco Use and Dependence (ATTUD); British Medical Association; Cancer Research UK; No Smoking Day; Pharmacy Health Link; Pip Mason Consultancy; QUIT; Royal College of Nursing; Society for the Study of Addiction.